Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Michael Celano > Profile

Michael Celano

Affiliations

  • Chief Financial Officer at Larimar Therapeutics Inc. (LRMR), 2025-01-24
  • Director at Orasure Technologies Inc (OSUR), 2022-08-16
  • Chief Operating Officer at Recro Pharma Inc. (REPH), 2019-02-19
  • Chief Financial Officer at Kensey Nash Corp (KNSY), 2012-06-26
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LRMR $3.73 5,000 $18,631.50 112,746 2023-05-17 Filing
LRMR $3.15 31,746 $99,999.90 31,746 2022-09-16 Filing
OSUR $4.49 12,000 $53,916.00 111,823 2022-08-12 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OSUR $14.95 44,962 $672,181.90 38,117 2017-05-05 Filing
OSUR $12.00 15,000 $180,000.00 83,079 2017-03-02 Filing
OSUR $10.06 10,000 $100,600.00 83,079 2017-02-09 Filing
OSUR $8.78 15,000 $131,700.00 93,079 2017-01-31 Filing